Literature DB >> 19549798

Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells.

Shiby Paul1, Agnes M Rimando, Hong Jin Lee, Yan Ji, Bandaru S Reddy, Nanjoo Suh.   

Abstract

Oxidative/nitrosative stress and generation of proinflammatory cytokines are hallmarks of inflammation. Because chronic inflammation is implicated in several pathologic conditions in humans, including cancers of the colon, anti-inflammatory compounds may be useful chemopreventive agents against colon cancer. Stilbenes, such as resveratrol, have diverse pharmacologic activities, which include anti-inflammation, cancer prevention, a cholesterol-lowering effect, enhanced insulin sensitivity, and increased life span. We previously showed that pterostilbene (trans-3,5-dimethoxy-4'-hydroxystilbene), a structural analogue of resveratrol, is present in blueberries and that pterostilbene inhibited expression of certain inflammation-related genes in the colon and suppressed aberrant crypt foci formation in rats. Here, we examined molecular mechanisms of the action of pterostilbene in colon cancer. Pterostilbene reduced cell proliferation, down-regulated the expression of c-Myc and cyclin D1, and increased the level of cleaved poly(ADP-ribose) polymerase. A combination of cytokines (tumor necrosis factor-alpha, IFN-gamma, and bacterial endotoxin lipopolysaccharide) induced inflammation-related genes such as inducible nitric oxide synthase and cyclooxygenase-2, which was significantly suppressed by treatment with pterostilbene. We further identified upstream signaling pathways contributing to the anti-inflammatory activity of pterostilbene by investigating multiple signaling pathways, including nuclear factor-kappaB, Janus-activated kinase-signal transducer and activator of transcription, extracellular signal-regulated kinase, p38, c-Jun NH(2)-terminal kinase, and phosphatidylinositol 3-kinase. Cytokine induction of the p38-activating transcription factor 2 pathway was markedly inhibited by pterostilbene among the different mediators of signaling evaluated. By silencing the expression of the p38 alpha isoform, there was significant reduction in cytokine induction of inducible nitric oxide synthase and cyclooxygenase-2. Our data suggest that the p38 mitogen-activated protein kinase cascade is a key signal transduction pathway for eliciting the anti-inflammatory action of pterostilbene in cultured HT-29 colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549798      PMCID: PMC2753521          DOI: 10.1158/1940-6207.CAPR-08-0224

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  48 in total

Review 1.  The p38 signal transduction pathway: activation and function.

Authors:  K Ono; J Han
Journal:  Cell Signal       Date:  2000-01       Impact factor: 4.315

2.  Drugs to prevent colon cancer show promise, but hurdles remain for chemoprevention.

Authors:  Rabiya Tuma
Journal:  J Natl Cancer Inst       Date:  2008-05-27       Impact factor: 13.506

3.  Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice.

Authors:  A M Reimold; J Kim; R Finberg; L H Glimcher
Journal:  Int Immunol       Date:  2001-02       Impact factor: 4.823

4.  Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol.

Authors:  Agnes M Rimando; Muriel Cuendet; Cristian Desmarchelier; Rajendra G Mehta; John M Pezzuto; Stephen O Duke
Journal:  J Agric Food Chem       Date:  2002-06-05       Impact factor: 5.279

5.  Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol.

Authors:  L A Stivala; M Savio; F Carafoli; P Perucca; L Bianchi; G Maga; L Forti; U M Pagnoni; A Albini; E Prosperi; V Vannini
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

6.  Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.

Authors:  Chinthalapally V Rao; Cooma Indranie; Barbara Simi; Pamela T Manning; Jane R Connor; Bandaru S Reddy
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

7.  Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis.

Authors:  Y Schneider; B Duranton; F Gossé; R Schleiffer; N Seiler; F Raul
Journal:  Nutr Cancer       Date:  2001       Impact factor: 2.900

Review 8.  Cancer as an overhealing wound: an old hypothesis revisited.

Authors:  Matthias Schäfer; Sabine Werner
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-16       Impact factor: 94.444

9.  Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity.

Authors:  Connie M Remsberg; Jaime A Yáñez; Yusuke Ohgami; Karina R Vega-Villa; Agnes M Rimando; Neal M Davies
Journal:  Phytother Res       Date:  2008-02       Impact factor: 5.878

10.  Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.

Authors:  Min-Hsiung Pan; Yen-Hui Chang; Mei-Ling Tsai; Ching-Shu Lai; Sheng-Yow Ho; Vladimir Badmaev; Chi-Tang Ho
Journal:  J Agric Food Chem       Date:  2008-07-26       Impact factor: 5.279

View more
  40 in total

1.  Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison.

Authors:  Wasamon Nutakul; Hana Shatara Sobers; Peiju Qiu; Ping Dong; Eric Andrew Decker; David Julian McClements; Hang Xiao
Journal:  J Agric Food Chem       Date:  2011-09-29       Impact factor: 5.279

2.  Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth.

Authors:  Cassia S Mizuno; Shiby Paul; Nanjoo Suh; Agnes M Rimando
Journal:  Bioorg Med Chem Lett       Date:  2010-10-14       Impact factor: 2.823

3.  A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.

Authors:  Jae Young So; Hong Jin Lee; Amanda K Smolarek; Shiby Paul; Chung-Xiou Wang; Hubert Maehr; Milan Uskokovic; Xi Zheng; Allan H Conney; Li Cai; Fang Liu; Nanjoo Suh
Journal:  Mol Pharmacol       Date:  2010-11-29       Impact factor: 4.436

4.  Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.

Authors:  Izet M Kapetanovic; Miguel Muzzio; Zhihua Huang; Thomas N Thompson; David L McCormick
Journal:  Cancer Chemother Pharmacol       Date:  2010-11-30       Impact factor: 3.333

Review 5.  Promise of resveratrol for easing status epilepticus and epilepsy.

Authors:  Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

6.  Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.

Authors:  Chi N Chan; Benjamin Trinité; David N Levy
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

7.  Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.

Authors:  Ibrahim Altamemi; E Angela Murphy; James F Catroppo; Elizabeth E Zumbrun; Jiajia Zhang; Jamie L McClellan; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

8.  Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.

Authors:  Shiby Paul; Andrew J DeCastro; Hong Jin Lee; Amanda K Smolarek; Jae Young So; Barbara Simi; Chung Xiou Wang; Renping Zhou; Agnes M Rimando; Nanjoo Suh
Journal:  Carcinogenesis       Date:  2010-01-08       Impact factor: 4.944

9.  Dietary pterostilbene supplementation attenuates intestinal damage and immunological stress of broiler chickens challenged with lipopolysaccharide.

Authors:  Hao Zhang; Yanan Chen; Yueping Chen; Yue Li; Peilu Jia; Shuli Ji; Yanmin Zhou; Tian Wang
Journal:  J Anim Sci       Date:  2020-01-01       Impact factor: 3.159

10.  Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid.

Authors:  Diana Serra; Joana Paixão; Carla Nunes; Teresa C P Dinis; Leonor M Almeida
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.